Dermatomyositis Recruiting Phase 4 Trials for Abatacept (DB01281)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02594735Abatacept in Juvenile DermatomyositisTreatment